Related Experiment Video
Updated: Jul 15, 2026
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
U.S. cancer incidence, mortality and survival: 1973-1996
1American Cancer Society, USA.
Statistical Bulletin (Metropolitan Life Insurance Company : 1984)
|July 27, 1999
Summary
Cancer incidence and mortality rates are declining, with significant improvements observed in lung, prostate, breast, and colorectal cancers. These positive trends, particularly notable in men, indicate progress in cancer control efforts.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Cancer morbidity and mortality rates have historically shown increases.
- Recent data suggests a reversal of these trends for major cancer sites.
Purpose of the Study:
- To analyze recent trends in cancer incidence and mortality for the four leading cancer sites.
- To assess the progress of predicted improvements in cancer morbidity and mortality.
Main Methods:
- Analysis of age-adjusted cancer incidence and mortality rates between 1990 and 1996.
- Comparison of trends across different cancer types and demographic groups (gender, race).
Main Results:
- Overall cancer incidence and mortality rates declined since 1992, with greater decreases in men.
- Lung cancer rates continue to decline in men, while women's rates are plateauing.
- Prostate cancer rates are decreasing but disparities persist between Black and White men.
- Breast cancer mortality rates declined by 1996, preceding predictions.
- Colorectal cancer incidence and mortality rates continued to decrease.
Conclusions:
- The study confirms earlier predictions of improved cancer morbidity and mortality.
- Significant progress has been made in reducing cancer burden, though disparities require attention.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
01:25Statistical Methods for Analyzing Epidemiological Data
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
01:18Introduction To Survival Analysis
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
The primary goal of survival analysis is to estimate survival time—the time until a...
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...